Document Type : Original Article


1 Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran

2 Cardiac Surgery Department, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran



Background: Open heart surgery is a prevalent therapeutic intervention for cardiovascular diseases. Significant adverse effects occur after heart surgery, one of which is patient readmission to the hospital.
Objective: The present study aimed to determine the relationship between performance indicators and the readmission of patients with open heart surgery in a teaching hospital in Iran.
Methods: This study was performed using a cross-sectional and descriptive method with a retrospective approach. Data was collected on a data collection form. The statistical population of this study comprised all patients who underwent open heart surgery from mid-September 2015 to mid-September 2016 in a teaching hospital in the north of Iran (n=849). Those patients readmitted to the hospital within 90 days after discharge, based on a review of patient records, were included in the study. Descriptive statistics and Spearman correlation coefficient were used for data analysis by SPSS 20.
Results: Among the patients who had open heart surgery in the selected hospital, 12.5% were readmitted within 90 days after discharge. The most important reasons for readmission in this study were infection in surgery place (25.8%), pleural effusion (18.7%), warfarin toxicity (9.8%), and tamponade (8.9%). There were inverse relationships between patient readmission and the two performance indicators of bed occupancy percentage (r = -0.594, P = 0.042) and bed turnover rate (r = -0.664, P = 0.018). There were no statistically significant relationships between any of the other indicators (length of stay, mortality, and bed turnover interval) and readmission rate (P > 0.1).
Conclusion: Hospital authorities can use these results for bed management and targeting interventions to reduce costs and readmissions as a measure of hospital quality. However, further research into readmission factors in other hospitals is recommended.


  1. Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25. doi:10.1016/j.jacc.2017.04.052.
  2. Min YI, Anugu P, Butler KR, et al. Cardiovascular disease burden and socioeconomic correlates: findings from the Jackson Heart Study. J Am Heart Assoc. 2017;6(8). doi:10.1161/JAHA.116.004416.
  3. Targonska-Stepniak B, Biskup M, Biskup W, Majdan M. Gender Differences in Cardiovascular Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity. Biomed Res Int. 2019;2019:3265847. doi:10.1155/2019/3265847.
  4. Raghfar H, Sargazi N, Mehraban S, Akbarzadeh MA, Vaez Mahdavi MR, Vahdati Manesh Z. The Economic Burden of Coronary Heart Disease in Iran: A Bottom-up Approach in 2014. Journal of Ardabil University of Medical Sciences. 2018;18(3):341-356. doi:10.29252/jarums.18.3.341. [Persian].
  5. Gharasi-Manshadi M, Meskarpour-Amiri M, Mehdizadeh P. Lost productivity among military personnel with cardiovascular disease. J R Army Med Corps. 2018;164(4):235-239. doi:10.1136/jramc-2018-000920.
  6. Bartel T, Rivard A, Jimenez A, Mestres CA, Muller S. Medical three-dimensional printing opens up new opportunities in cardiology and cardiac surgery. Eur Heart J. 2018;39(15):1246- 1254. doi:10.1093/eurheartj/ehx016.
  7. Afilalo J, Kim S, O’Brien S, et al. Gait speed and operative mortality in older adults following cardiac surgery. JAMA Cardiol. 2016;1(3):314-321. doi:10.1001/jamacardio.2016.0316.
  8. Hosseini M, Ramazani J. The predictors of morbidities after cardiac surgery. Journal of Iranian Society of Anesthesiology and Critical Care. 2013;35(82). [Persian].
  9. Redzek A, Mironicki M, Gvozdenovic A, et al. Predictors for hospital readmission after cardiac surgery. J Card Surg. 2015;30(1):1-6. doi:10.1111/jocs.12441.
  10. Borregaard B, Dahl JS, Riber LPS, et al. Effect of early, individualised and intensified follow-up after open heart valve surgery on unplanned cardiac hospital readmissions and all-cause mortality. Int J Cardiol. 2019;289:30-36. doi:10.1016/j.ijcard.2019.02.056.
  11. Greco G, Shi W, Michler RE, et al. Costs associated with health care-associated infections in cardiac surgery. J Am Coll Cardiol. 2015;65(1):15-23. doi:10.1016/j.jacc.2014.09.079.
  12. Shih T, Dimick JB. Reliability of readmission rates as a hospital quality measure in cardiac surgery. Ann Thorac Surg. 2014;97(4):1214-1218. doi:10.1016/j.athoracsur.2013.11.048.
  13. Wang H, Robinson RD, Johnson C, et al. Using the LACE index to predict hospital readmissions in congestive heart failure patients. BMC Cardiovasc Disord. 2014;14:97. doi:10.1186/1471-2261-14-97.
  14. Donze JD, Williams MV, Robinson EJ, et al. International validity of the HOSPITAL score to predict 30-day potentially avoidable hospital readmissions. JAMA Intern Med. 2016;176(4):496- 502. doi:10.1001/jamainternmed.2015.8462.
  15. Honeyford K, Aylin P, Bottle A. Should Emergency Department Attendances be Used With or Instead of Readmission Rates as a Performance Metric?: Comparison of Statistical Properties Using National Data. Med Care. 2019;57(1):e1-e8. doi:10.1097/MLR.0000000000000899.
  16. Hoyer EH, Padula WV, Brotman DJ, et al. Patterns of Hospital Performance on the Hospital-Wide 30-Day Readmission Metric: Is the Playing Field Level? J Gen Intern Med. 2018;33(1):57-64. doi:10.1007/s11606-017-4193-9.
  17. Gilstrap LG, Joynt KE. Understanding the relationship between readmission and quality of hospital care in heart failure. Curr Heart Fail Rep. 2014;11(4):347-353. doi:10.1007/s11897-014-0209-5.
  18. Iribarne A, Chang H, Alexander JH, et al. Readmissions after cardiac surgery: experience of the National Institutes of Health/ Canadian Institutes of Health research cardiothoracic surgical trials network. Ann Thorac Surg. 2014;98(4):1274-1280. doi:10.1016/j.athoracsur.2014.06.059.
  19. Mirzaeyan S, Izadi AR, Ebrazeh A, Mohammadi P. Prediction of readmission based on LACE index in medical ward of Hajar hospital of Shahrekord. Journal of Clinical Nursing and Midwifery. 2014;3(2):1-12. [Persian].
  20. Blom MC, Erwander K, Gustafsson L, Landin-Olsson M, Jonsson F, Ivarsson K. The probability of readmission within 30 days of hospital discharge is positively associated with inpatient bed occupancy at discharge--a retrospective cohort study. BMC Emerg Med. 2015;15:37. doi:10.1186/s12873-015-0067-9.
  21. Lingsma HF, Bottle A, Middleton S, Kievit J, Steyerberg EW, Marang-van de Mheen PJ. Evaluation of hospital outcomes: the relation between length-of-stay, readmission, and mortality in a large international administrative database. BMC Health Serv Res. 2018;18(1):116. doi:10.1186/s12913-018-2916-1.
  22. Rao A, Kim D, Darzi A, Majeed A, Aylin P, Bottle A. Regional variations in trajectories of long-term readmission rates among patients in England with heart failure. BMC Cardiovasc Disord. 2019;19(1):86. doi:10.1186/s12872-019-1057-8.
  23. Espinoza J, Camporrontondo M, Vrancic M, et al. 30-day readmission score after cardiac surgery. Clin Trials Regul Sci Cardiol. 2016;20:1-5. doi:10.1016/j.ctrsc.2016.05.006.
  24. Magnus PC, Chaisson K, Kramer RS, et al. Causes of 30-day readmission after cardiac surgery in Northern New England. J Am Heart Assoc. 2011;124(21):A13474.
  25. Sud M, Yu B, Wijeysundera HC, et al. Associations between short or long length of stay and 30-day readmission and mortality in hospitalized patients with heart failure. JACC Heart Fail. 2017;5(8):578-588. doi:10.1016/j.jchf.2017.03.012.
  26. Maniar HS, Bell JM, Moon MR, et al. Prospective evaluation of patients readmitted after cardiac surgery: analysis of outcomes and identification of risk factors. J Thorac Cardiovasc Surg. 2014;147(3):1013-1018. doi:10.1016/j.jtcvs.2013.10.066.
  27. Do TNP, Do QH, Cowie MR, et al. Effect of the Optimize Heart Failure Care Program on clinical and patient outcomes - The pilot implementation in Vietnam. Int J Cardiol Heart Vasc. 2019;22:169-173. doi:10.1016/j.ijcha.2019.02.010.
  28. Parker DM, Everett AD, Stabler ME, et al. Biomarkers associated with 30-day readmission and mortality after pediatric congenital heart surgery. J Card Surg. 2019;34(5):329-336. doi:10.1111/jocs.14038.